Renibus Presents Phase 2 Results on RBT-1, a First-in-Class Preconditioning Agent, at the American Society for Enhanced Recovery and Perioperative Medicine (ASER PM) 2023 Meeting
- Monday, September 11, 2023, 7:00
- Finance
- Add a comment
-Results demonstrate that treatment with RBT-1 prior to cardiac surgery may reduce the risk of post-operative anemia and need for blood transfusion and iron supplementation- -Pivotal Phase 3 study of RBT-1 to be initiated in Q4 2023- SOUTHLAKE, Texas, Sept. 11, 2023 /PRNewswire/ –…
About the Author
adminasapcorp has written 39013 stories on this site.